Approximately half of the LR-CHL cases (46%) showed CXCL13+ T cells surrounding HRS cells (“rosettes”), whereas only 13% of patients with other CHL subtypes showed CXCL13+ T cell rosettes. This evidence concerns the gene CXCL13 and classic Hodgkin lymphoma.